Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Neuroimmune Pharmacology is Scopus-indexed (Q1, CiteScore 6.4), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 1557-1890Verify ISSN ↗1557-1904Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$4,790 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neuroscience (miscellaneous) | 14 / 74 | 81st | Q1 |
| Pharmacology | 94 / 328 | 71st | Q2 |
| Immunology and Allergy | 79 / 234 | 66th | Q2 |
| Immunology | 86 / 243 | 64th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q1, CiteScore 6.4.
Journal of Neuroimmune Pharmacology is Q1 in Neuroscience (miscellaneous) (rank 14 of 74), Q2 in Pharmacology (rank 94 of 328) and Q2 in Immunology and Allergy (rank 79 of 234), by CiteScore 2025. It is ranked in 4 subject areas in all.
Journal of Neuroimmune Pharmacology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.4, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.458, quartile Q1, with an H-index of 99.
The publisher lists an article processing charge of about US$4,790 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Neuroimmune Pharmacology is published by Springer. Its print ISSN is 1557-1890 and its online ISSN is 1557-1904.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Neuroimmune Pharmacology has an h-index of 109 and a 2-year mean of 5.97 citations per paper (OpenAlex). Its Scopus CiteScore is 6.4, quartile Q1. On 2-year citations it ranks #6 of 73 Scopus journals in Neuroscience (miscellaneous).
Journal of Neuroimmune Pharmacology published 106 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from China (30.4%), United States (15%) and India (10.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.